BDH Industries Limited (BOM:524828)

Market Cap	1.52B
Revenue (ttm)	665.08M
Net Income (ttm)	92.73M
Shares Out	5.76M
EPS (ttm)	16.11
PE Ratio	16.39
Forward PE	n/a
Dividend	4.50 (1.70%)
Ex-Dividend Date	Aug 2, 2024

Volume	151
Average Volume	1,948
Open	259.70
Previous Close	256.10
Day's Range	250.25 - 259.70
52-Week Range	241.00 - 417.85
Beta	0.06
RSI	53.32
Earnings Date	May 16, 2025

About BDH Industries

BDH Industries Limited engages in the manufacture and sale of therapeutic formulations covering a range of pharmaceuticals in India. The company operates through two segments, Pharmaceuticals and Renewable Energy segments. It provides analgesic/antipyretic, analgesic balm, antacids, acaricide, anthelmintics, antiprotozoal, aniti-glaucoma, antiseptics, anti-psychotics, anti-tuberculosis, anti-allergics, anti-tussive, antiasthamatics, antibacterial, antiseptic, anticancer, anticoagulants, anticonvulsants, antidiabetics, anti-emetics, antifungal, ...

• Industry: Pharmaceutical Preparations
• Founded: 1935
• Employees: 117
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524828

Financial Performance

In 2024, BDH Industries's revenue was 665.08 million, a decrease of -22.51% compared to the previous year's 858.31 million. Earnings were 92.73 million, a decrease of -6.02%.